Member Info for Nolupus

Th r&d costs are done for Lupuzor ?? The extension trial and the MAP are free of charge, now ??

Nucant is being sold when ?
The Incanthera float has been postponed for now so ??

Please be realistic RDR ....

RDR....The cash is dwindling, especially since Tim filled Incanthera's hole to the tune of 2 million quid....IMM are financing all the R&D costs for Lupuzor, Nucant and Bordeaux as well as the fat salaries for management....I am awaiting the year end results to see exactly how much cash is left...

Map Partner ?? or Map contractor ?

Imm are the only one footing the bills so i can't see what difference this will make to the SP ...Please enlighten me ..

Pokerchips; a fund raising at this level ?? It would take some serious good news before any II would back it...imo

Pokerchips, Time is running out as is the Cash....but everyone to their own opinion

Trek, it's been nearly a year since the P3 RESULTS....and lupuzor has gone off the radar as far as i can see ...If the "market" believed in it's potentiel, i think a partner would have signed up long ago...would'nt you agree ?

Trek, It's a bit difficult to have rose tinted glasses at this time....

When analysing IMM, the signals are not very optimistic, imv

Lupuzor...No representation at Lupus 2019 and no news from Muller since ??
Incanthera...Option not finalised and IPO postponed until ??
Ureka...No sale at this time

In the meantime, Imm are paying for Nucant and Ureka as well as the r&d costs for lupuzor from ever dwindling cash..

If you see anything rosy through your glasses ..please let me know..

a-2-b

Looking at the volume, i can't see your logic :-)

https://issuu.com/integritasgrp/docs/2018_acr_lupus_workbook?fbclid=IwAR3d97dBFJ-417SFBsJjlVMpGk9W2XnOhGzsm7Lbs8f6iAzY76rMeYrsk-w

Talk is cheap, as cheap as tweets :-)

The pumpers are strangely absent....

Waiting on official updates so in the meantime ...hibernation

to the rescue...
sweets and dolls for RDR

RdR

BS ??

Can you please find fault with my calculations ??

As you should already know, IMM have rarely been consistent in their recent "deadlines" :-)

recrutement finished in sept...+ 6 months treatment + analysis and reporting time, takes us to near the end of Q2, imv

RdR

The must disturbing imv, is the lack of news out of France...CNRS or Eureka....

I cannot figure out why people are expecting any major newsflow and therefore a rise to sp in the near future ....

Okay...We expect an update on the Map program. in the first quarter...We expect news on the Nucant option in this quarter as well as the financial results for 2018...( We will need to see how much is left in the bank, (Cash not just "net assets")

Any surprises to come ?? IMM needs some ...

Nothing expected until the end of the second quarter....

Retour du renard...SO ...Chairman Tim has offloaded Nucant to Incanthera in exchange for a 2 million investment by IMM into Incanthera ...old news that...
What we are awaiting is the takeup of Incanthera on the Nucant option ( with an upfront payment of 1 million quid worth of Incanthera's shares ) shares not CASH...

Imm can fund the Map program on their own cash without any outside funding ( estimated cost of roughly 1 million according to an interview that Tim did, months ago )

"Maybe they didn’t have to go." ??

Any company involved in Lupus treatments would be honored to participate...imv

The most important congress on Lupus Is being held in San Francisco this year ( April.5-8 )

Where are IMM ?

http://lupus2019sf.org/

https://www.medpagetoday.com/rheumatology/lupus/77524